0001179110-19-011701.txt : 20191114
0001179110-19-011701.hdr.sgml : 20191114
20191114174521
ACCESSION NUMBER: 0001179110-19-011701
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20191104
FILED AS OF DATE: 20191114
DATE AS OF CHANGE: 20191114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dummer Wolfgang
CENTRAL INDEX KEY: 0001749991
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-29889
FILM NUMBER: 191221858
MAIL ADDRESS:
STREET 1: 5491 OPTICAL CT.
CITY: SAN JOSE
STATE: CA
ZIP: 95138
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001034842
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943248524
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
MAIL ADDRESS:
STREET 1: 1180 VETERANS BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
edgar.xml
FORM 3 -
X0206
3
2019-11-04
1
0001034842
RIGEL PHARMACEUTICALS INC
RIGL
0001749991
Dummer Wolfgang
C/O RIGEL PHARMACEUTICALS, INC.
1180 VETERANS BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
/s/ Dolly Vance (Attorney-in-Fact)
2019-11-14
EX-24
2
ex24dummer.txt
POWER OF ATTORNEY
The undersigned hereby appoints each of Dolly A. Vance and Dean Schorno,
signing individually, the undersigned's true and lawful attorneys-in-fact and
agents to:
(1) execute for and on behalf of the undersigned, an officer, director
or holder of 10% or more of a registered class of securities of Rigel
Pharmaceuticals, Inc. (the "Company"), Forms 3,4, and 5 in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for an on behalf of the undersigned
that may be necessary or desirable to complete and execute such Form 3,4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the
earliest to occur of (a) the undersigned is no longer required to file Forms 3,
4 and 5 with respect to the undersigned's holdings of and transactions in
securities issued by the Company, (b) revocation by the undersigned in a signed
writing delivered to the foregoing attorneys-in-fact, or (c) as to any
attorney-in-fact individually, until such attorney-in-fact shall no longer be
employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 4th day of November, 2019.
/s/ Wolfgang Dummer
---------------------------
Wolfgang Dummer, MD, PhD